Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600329)"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2026
Filed with SSE · Stock code 600329 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited on 6ix
Story so far
- Indicative Announcement on Listing and Transfer of 100% Equity Interest in Shanghai Liuliguang Pharmaceutical Development Co., Ltd. by Shanghai Industrial Investment (Holdings) Co., Ltd. and Shanghai Industrial Investment Development Co., Ltd.
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing and Attending the Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction
Earlier from Tianjin Pharmaceutical Da Ren Tang
- (600329)"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Obtaining Drug Registration Certificate by a Branch
- Indicative Announcement on Listing and Transfer of 100% Equity Interest in Shanghai Liuliguang Pharmaceutical Development Co., Ltd. by Shanghai Industrial Investment (Holdings) Co., Ltd. and Shanghai Industrial Investment Development Co., Ltd.
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
- Announcement on Resolutions of the 8th Meeting of the Board of Directors in 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing and Attending the Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction
Follow Tianjin Pharmaceutical Da Ren Tang into a list and get an email when it puts out news.
Follow Tianjin Pharmaceutical Da Ren Tang